136.00CHF+0.29%Mkt Cap: 3.09B $P/E: 30.911d ago
Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Latin America, North America, the Asia-Pacific, and Middle East and Africa. It offers personalized 3D planning tools f…
Indicators:|
Key Statistics
Company
Market Cap3.09B $
Enterprise Value3.35B $
Revenue (TTM)780.45M $
Gross Profit523.47M $
Net Income (TTM)108.95M $
Revenue/Share39.17 USD
Last Price136.00 CHF
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees2.0K
CountryCH
SectorHealthcare
IndustryMedical Devices
ISINCH0468525222
Valuation
P/E (Trailing)30.91
P/E (Forward)24.50
PEG—
EV/EBITDA17.09
EV/Revenue4.30
P/S3.96
P/B6.45
EPS (TTM)4.40
EPS (Forward)5.55
52W Range
129.2014% of range177.20
52W High177.20 CHF
52W Low129.20 CHF
Profitability
Gross Margin67.07%
Oper. Margin15.96%
EBITDA Margin25.13%
Profit Margin13.96%
ROE20.91%
ROA10.40%
Growth
Revenue Growth12.50%
Earnings Growth1.20%
Cash Flow & Leverage
Operating CF174.22M $
CapEx (TTM)163.32M $
FCF Margin-4.91%
FCF Yield-1.24%
Net Debt261.99M $
Net Debt/EBITDA1.34
Balance Sheet
Debt/Equity0.57
Current Ratio2.08
Quick Ratio0.77
Book Value/Sh21.10 CHF
Cash/Share1.668 CHF
Dividends
Fwd Div Rate1.100 CHF
Trail. Div Rate1.181 CHF
Div. Yield0.81%
5Y Avg Yield—
Payout Ratio15.48%
Ex-Div DateMay 7, 2026
Pay DateMay 13, 2025
Analyst Consensus
Rating1.6 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)178.96 CHF
Upside (mean)+31.6%
Target Range148.04 CHF – 194.58 CHF
CHF148.04+31.6% to meanCHF194.58
# Analysts5
Ownership
Shares Out.19.91M
Float6.00M
Insiders69.66%
Institutions18.36%
Technical
SMA 50140.30 (-3.1%)
SMA 200150.61 (-9.7%)
Beta0.99
S&P 52W Chg20.05%
Avg Vol (30d)17.63K
Avg Vol (10d)23.16K
Technical Indicators
RSI (14)46.5
MACD-1.5743
MACD Signal-2.1161
MACD Hist.+0.5419
BB Upper139.27 CHF
BB Middle135.61 CHF
BB Lower131.95 CHF
BB Width5.39%
ATR (14)3.702 CHF
Vol Ratio (20d)1.63x